Cargando…
MS, pregnancy and COVID-19
Concerns regarding infection with the novel coronavirus SARS-CoV-2 leading to COVID-19 are particularly marked for pregnant women with autoimmune diseases such as multiple sclerosis (MS). There is currently a relative paucity of information to guide advice given to and the clinical management of the...
Autores principales: | Yam, Charmaine, Jokubaitis, Vilija, Hellwig, Kerstin, Dobson, Ruth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493203/ https://www.ncbi.nlm.nih.gov/pubmed/32924838 http://dx.doi.org/10.1177/1352458520949152 |
Ejemplares similares
-
Treatment of Women with Multiple Sclerosis Planning Pregnancy
por: Krysko, Kristen M., et al.
Publicado: (2021) -
The MSBase pregnancy, neonatal outcomes, and women’s health registry
por: Jokubaitis, Vilija G., et al.
Publicado: (2021) -
A new role for evoked potentials in MS? Repurposing evoked potentials as biomarkers for clinical trials in MS
por: Hardmeier, Martin, et al.
Publicado: (2017) -
Rituximab, MS, and pregnancy
por: Smith, Jessica B., et al.
Publicado: (2020) -
Focus on neglected features of cognitive rehabilitation in MS:
Setting and mode of the treatment
por: Podda, Jessica, et al.
Publicado: (2020)